THE INTERSECTION OF BRAIN SCIENCE & HUMAN POTENTIALPartner with us
neurofeedback.com
The newsletter
← Research & Evidence
Positive with limitationsTMS-EEG analysis embedded in a randomized active-comparator add-on trial

Dorsolateral prefrontal TMS-evoked N100 as a neurophysiological correlate of symptom change in adolescent depression

Published online October 14, 2026. A change in a TMS-EEG signal tracked symptom improvement, particularly among girls, but the two exercise conditions did not differ. The signal is a research correlate, not a diagnostic or treatment-selection test.

Klomfass S, Loy JK, Wunram HL, Biermann L, Pokorny L, Bender S.
Journal of Psychiatric Research · Publication date: 2026-10-14
Added to site: 2026-10-18
DOI: 10.1016/j.jpsychires.2026.10.013

First published online October 14, 2026; assigned to the January 2027 issue. Added to Neurofeedback.com October 18, 2026.

Modalities
TMS-EEG, ERP, EEG
Clinical focus
Adolescent depression, N100, Neurophysiological correlate
Population
Adolescents with major depressive disorder receiving treatment as usual
Sample
54 adolescents: 38 girls and 16 boys
Intervention / method
Participants received six weeks of whole-body vibration training or light stretching as an add-on to treatment as usual. Left and right dorsolateral-prefrontal TMS-evoked N100 amplitudes and depression ratings were measured before and after treatment.
Comparator
Whole-body vibration training versus light stretching, both added to treatment as usual

Clinician summary

N100 amplitudes decreased across both groups with no differential intervention effect. Greater reduction in right-hemisphere N100 amplitude was associated with greater symptom improvement, reaching significance in girls. This is an association within an add-on trial, not prospective biomarker validation.

How to interpret the findings

Modest sample, sex imbalance, no differential treatment effect, secondary correlational analysis and girls-only follow-up. The study does not show that N100 predicts future response, identifies causal mechanism or supports clinical decision-making on its own.

Equipment and disclosures

TMS-EEG acquisition and stimulation-system manufacturers were not identified in the checked abstract. No BrainMaster attribution.

The authors declared no known competing financial interests or personal relationships. Funding was not reported in the checked abstract. No indexed correction, retraction or concern notice appeared in the retained PubMed or Crossref records; this is a bounded check. AI-assisted review.

Related evidence

Compare findings from the same clinical area, including mixed results.

Abstract checked · Checked 2026-10-18

Summary prepared with AI assistance. Source verification does not imply an independent replication or a clinician's endorsement. Read our review method.